MaxCyte, Inc.MXCTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank85
3Y CAGR+4.8%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+4.8%/yr
Annual compound
Percentile
P85
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$4.36M-57.0%
2024$10.14M-2.3%
2023$10.38M+173.8%
2022$3.79M+524.1%
2021$-893600.00-17.6%
2020$-759700.00-59.9%
2019$-475000.00-6.9%
2018$-444300.00+28.9%
2017$-625300.00-0.5%
2016$-622100.00-